Holen Sie sich die Stockscreener-App
3.21
5.59%
0.17
Handel nachbörslich:
3.29
0.08
+2.49%
Schlusskurs vom Vortag:
$3.04
Offen:
$3.08
24-Stunden-Volumen:
5.97M
Relative Volume:
0.66
Marktkapitalisierung:
$1.52B
Einnahmen:
$1.70B
Nettoeinkommen (Verlust:
$-123.70M
KGV:
-5.8802
EPS:
-0.5459
Netto-Cashflow:
$-178.21M
1W Leistung:
-3.60%
1M Leistung:
-19.75%
6M Leistung:
+260.67%
1J Leistung:
+214.71%
1-Tages-Spanne:
$3.05
$3.26
1-Wochen-Bereich:
$2.99
$3.34
52-Wochen-Spanne:
$0.606
$4.71
Clover Health Investments Corp Stock (CLOV) Company Profile
Firmenname
Clover Health Investments Corp
Sektor
Branche
Telefon
(201) 432-2133
Adresse
3401 MALLORY LANE, SUITE 210, FRANKLIN
Vergleichen Sie CLOV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| CLOV | 3.21 | 1.52B | 1.70B | -123.70M | -178.21M | -0.5459 |
| UNH | 589.65 | 544.99B | 389.07B | 14.32B | 13.10B | 23.04 |
| ELV | 400.70 | 92.77B | 174.02B | 6.42B | 871.00M | 25.47 |
| CI | 322.45 | 89.32B | 229.75B | 3.04B | 5.18B | 17.73 |
| CVS | 56.05 | 70.53B | 368.91B | 5.02B | 1.69B | 6.63 |
| HUM | 271.35 | 32.67B | 115.01B | 1.36B | -4.34B | 24.12 |
Clover Health Investments Corp Stock (CLOV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-02-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-02-02 | Hochstufung | Cowen | Underperform → Market Perform |
| 2022-01-19 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2022-01-10 | Fortgesetzt | Citigroup | Neutral |
| 2022-01-07 | Herabstufung | Credit Suisse | Neutral → Underperform |
| 2021-09-10 | Eingeleitet | Cowen | Underperform |
| 2021-09-02 | Fortgesetzt | Citigroup | Neutral |
| 2021-07-12 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-06-10 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-05-17 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-03-09 | Eingeleitet | Credit Suisse | Neutral |
| 2021-02-02 | Eingeleitet | Citigroup | Buy |
| 2021-02-01 | Eingeleitet | JP Morgan | Neutral |
Alle ansehen
Clover Health Investments Corp Aktie (CLOV) Neueste Nachrichten
Clover Health: Buy The Dip, Reap The Rewards - Seeking Alpha
Clover Health Investments, Corp. (NASDAQ:CLOV) Sees Significant Increase in Short Interest - MarketBeat
GSA Capital Partners LLP Reduces Stock Position in Clover Health Investments, Corp. (NASDAQ:CLOV) - MarketBeat
Down -26.32% in 4 Weeks, Here's Why Clover Health Investments (CLOV) Looks Ripe for a Turnaround - Yahoo Finance
2024's 10 Best-Performing Stocks | Investing - U.S News & World Report Money
Bears are Losing Control Over Clover Health Investments (CLOV), Here's Why It's a 'Buy' Now - MSN
Avant Technologies Launches AI Healthcare Venture to Transform $188B Medical Imaging Market | CLOV Stock News - StockTitan
What is Leerink Partnrs' Estimate for CLOV FY2024 Earnings? - MarketBeat
Clover Health Investments Corp (CLOV) Quarterly 10-Q Report - Quartzy
Clover Health Investments, Corp. (NASDAQ:CLOV) Q3 2024 Earnings Call Transcript - Insider Monkey
Leerink Partnrs Issues Positive Forecast for CLOV Earnings - MarketBeat
Clover Health Investments, Corp. (NASDAQ:CLOV) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates - Simply Wall St
Clover Health Investments Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Clover Health Investments Corp (CLOV) Q3 2024 Earnings Call High - GuruFocus.com
Clover Health Investments Corp (CLOV) Q3 2024 Earnings Call Highlights: Strong Financial - Yahoo Finance
Clover Health Investments (NASDAQ:CLOV) Shares Gap DownTime to Sell? - MarketBeat
CLOV Stock Declines Despite Q3 Earnings Beat, FY24 View Revised - Yahoo Finance
December 27th Options Now Available For Clover Health Investments (CLOV) - Nasdaq
Clover Health Reports Strong Financial Growth in Q3 2024 - TipRanks
Clover Health drops 13% as Q3 revenue misses mark - MSN
Clover Health Investments, Corp. (CLOV) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance Australia
Clover Health Investments earnings beat by $0.02, revenue fell short of estimates By Investing.com - Investing.com
Clover Health Reports Strong Third Quarter 2024 Financial Results; Highlights Differentiated Market Opportunity to Grow Membership - The Manila Times
Clover Health Investments, Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Clover Health's Rally: The Payoff Of A Profitable Pivot (NASDAQ:CLOV) - Seeking Alpha
Clover Health Investments, Corp. (NASDAQ:CLOV) Q2 2024 Earnings Call Transcript - MSN
What To Expect From Clover Health Investments Corp (CLOV) Q3 202 - GuruFocus.com
What To Expect From Clover Health Investments Corp (CLOV) Q3 2024 Earnings - Yahoo Finance
Clover Health stock rallies 22% post-market on Iowa Clinic deal - MSN
Vanguard Group Inc's Strategic Acquisition of Clover Health Inve - GuruFocus.com
CLOV Q3 Estimates Unchanged Before Earnings: How to Play the Stock? - MSN
Clover Health Investments (STU:7QD) Net-Net Working Capital : €0.06 (As of Jun. 2024) - GuruFocus.com
2024's 10 Best-Performing Stocks - MSN
Clover Health Investments (CLOV) Scheduled to Post Earnings on Wednesday - MarketBeat
Clover Health to Participate in Upcoming Investor Conferences - The Manila Times
Here's Why We're Watching Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation - Yahoo Finance
CLOVClover Health Investments, Corp Latest Stock News & Market Updates - StockTitan
Clover Health to exit Medicare ACO REACH program - MSN
Clover Health Investments, Corp. (NASDAQ:CLOV) Short Interest Down 38.3% in October - MarketBeat
Clover Health Settles Legal Fees for $250,000 in Bylaw Suit - Investing.com India
Clover Health Settles Legal Fees for $250,000 in Bylaw Suit By Investing.com - Investing.com UK
Clover Health to Report Third Quarter 2024 Financial Results on November 6 - The Manila Times
Clover Health Investments (NASDAQ:CLOV) Shares Up 4%Here's What Happened - MarketBeat
Clover Health Investments (NASDAQ:CLOV) Shares Down 3.1%What's Next? - MarketBeat
Jim Cramer On Clover Health Investments, Corp. (CLOV): ‘I Just Don’t Want To Go There’ - Insider Monkey
CLOV stock touches 52-week high at $4.44 amid market rally - Investing.com Australia
Finanzdaten der Clover Health Investments Corp-Aktie (CLOV)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.79%
7.46%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):